Tretinoin and Metformin Interaction: What You Need to Know

What the tretinoin label's interactions section covers

Renova 0.02% cream is indicated as an adjunct for the mitigation of fine facial wrinkles [2]. Its drug interactions section lists other topical medications, medicated or abrasive soaps, shampoos, cleansers and cosmetics with a strong drying effect, products with high concentrations of alcohol, astringents, spices, lime, permanent wave solutions, electrolysis, hair depilatories and waxes, because these may increase irritation [2]. It also names drugs known to be photosensitizers - thiazides, tetracyclines, fluoroquinolones, phenothiazines and sulfonamides - and says the cream should not be used with them because of possible augmented phototoxicity [2].

Retin-A and Retin-A Micro are acne products with their own labels, worded separately from Renova's.

What the metformin label flags instead

The metformin label's interaction table is short and specific [1]:

• Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide) can lower serum bicarbonate and cause a non-anion gap acidosis, raising lactic acidosis risk; more frequent monitoring is suggested [1].
• Drugs that interfere with the renal transporters OCT2 and MATE (ranolazine, vandetanib, dolutegravir, cimetidine) can raise metformin exposure and may increase lactic acidosis risk; the label says to weigh benefits and risks [1].
• Alcohol potentiates metformin's effect on lactate metabolism, and the label warns against excessive intake [1].
• Insulin and insulin secretagogues such as sulfonylureas raise hypoglycemia risk, and lower doses of those may be needed [1].
• Drugs that raise blood glucose - thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazid - can cause loss of glycemic control, so the label says to watch closely [1].

Thiazides and phenothiazines appear on both lists: on metformin's as drugs that raise blood glucose, and on Renova's as photosensitizers [1][2].

How much tretinoin gets into the blood

The Renova label reports that transdermal absorption of tretinoin from various topical formulations ranged from 1% to 31% of the applied dose, depending on whether it was applied to healthy or dermatitic skin [2]. With a radiolabeled 0.05% cream in 7 healthy men, absorption after a single application was less than 2%, and after repeated daily application for 28 days in 7 men it was again less than 2%, with the extent of bioavailability lower after repeated use [2]. No percutaneous absorption study was run with Renova 0.02% itself in human volunteers, and no significant difference in endogenous tretinoin concentrations was seen between single and repeated daily applications [2].

Metformin: no metabolism, kidney clearance

Metformin is not metabolized, is negligibly bound to plasma proteins and is cleared by the kidneys [1]. It is excreted unchanged in urine by tubular secretion, with renal clearance about 3.5 times creatinine clearance; plasma half-life is about 6.2 hours, and about 90% of an absorbed dose is cleared within 24 hours [1]. Food lowers absorption, with an 850 mg tablet taken with food producing a peak about 40% lower and an AUC 25% lower [1].

Topical tretinoin is not oral isotretinoin

Topical tretinoin is a different drug product from oral isotretinoin (Accutane-type capsules), which has a boxed warning and a REMS. Renova's reported adverse reactions were primarily skin reactions, including peeling, dry skin, burning, stinging, redness and itching [2].

What to watch for with metformin

Metformin carries a boxed warning for lactic acidosis, with postmarketing cases that resulted in death, hypothermia, hypotension and resistant bradyarrhythmias [1]. Onset is often subtle - malaise, myalgias, respiratory distress, somnolence, abdominal pain - and the laboratory picture includes blood lactate above 5 mmol/L, anion gap acidosis, a raised lactate/pyruvate ratio and metformin levels generally above 5 mcg/mL [1]. Named risk factors are renal impairment, certain drugs such as carbonic anhydrase inhibitors, age 65 or older, radiologic contrast studies, surgery and other procedures, hypoxic states such as acute heart failure, excessive alcohol intake, hepatic impairment and mitochondrial disease [1]. The label says that when lactic acidosis is suspected, metformin is discontinued and supportive care is given in a hospital, and it recommends prompt hemodialysis [1].

Kidney function is checked with eGFR before starting and at least yearly; metformin is contraindicated below 30 mL/min/1.73 m2, starting is not recommended at 30 to 45, and the label says to reassess benefit and risk if eGFR later falls below 45 [1]. For iodinated contrast, the label says to stop metformin at the time of or before the procedure in patients with eGFR 30 to 60, a history of liver disease, alcoholism or heart failure, or when intra-arterial contrast is used, then recheck eGFR at 48 hours and restart only if renal function is stable [1].

On B12, the label reports subnormal levels in about 7% of patients in 29-week trials and asks for hematologic parameters annually and vitamin B12 every 2 to 3 years [1]. In the Diabetes Prevention Program Outcomes Study, low B12 (203 pg/mL or less) occurred in 4.3% of metformin users versus 2.3% of placebo users at 5 years (P=0.02) and 7.4% versus 5.4% at 13 years, which was not statistically significant [3].

Gastrointestinal effects are the common ones: in the label's US trial of 141 metformin and 145 placebo patients, diarrhea occurred in 53% versus 12%, nausea or vomiting in 26% versus 8%, and diarrhea led to discontinuation in 6% [1].

What to watch for with tretinoin

In Renova's double-blind vehicle-controlled studies of 339 patients, almost all reported one or more local reactions - peeling, dry skin, burning, stinging, erythema and itching - and in 32% the irritation was severe, led to temporary discontinuation, or required a mild topical corticosteroid; about 4% discontinued because of adverse reactions [2].

The label advises avoiding or minimizing sun and sunlamps, not using the product on sunburned skin until fully recovered, and using sunscreen with a minimum SPF of 15 plus protective clothing [2]. It also says Renova should not be given to patients taking drugs known to be photosensitizers [2]. The Renova label says to wash with mild soap, pat the skin dry, wait 20 to 30 minutes, then apply a pearl-sized amount in the evening, avoiding the eyes, ears, nostrils and mouth [2]. Larger amounts have not been shown to work faster and may cause marked redness, peeling or discomfort [2].

Timing and dosing

Metformin immediate-release starts at 500 mg twice daily or 850 mg once daily with meals, increasing by 500 mg weekly or 850 mg every 2 weeks to a maximum of 2,550 mg a day; doses above 2,000 mg may be better tolerated three times daily [1]. Extended-release tablets are swallowed whole and started at 500 mg once daily with the evening meal, increasing by 500 mg weekly to a maximum of 2,000 mg once daily [4]. Metformin is taken with meals [1]; tretinoin cream is applied once daily in the evening [2].

Pregnancy and the tretinoin label

Wording differs by tretinoin product. The Renova label says not to use the cream if the patient is pregnant, attempting to become pregnant or at high risk of pregnancy [2]. Older acne labels say tretinoin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, some generic labels print Pregnancy Category C, and the 2025 Retin-A Micro label says decades of published prospective and retrospective studies have not established a drug-associated risk of major birth defects, miscarriage or adverse outcomes, while noting their methodological limits. None of the labels reviewed calls topical tretinoin contraindicated in pregnancy.

For metformin, the label reports limited pregnancy data, with published studies showing no clear association with major birth defects or miscarriage, and advises discussing unintended pregnancy with premenopausal women because metformin may result in ovulation in some anovulatory women [1].